[Multiple sclerosis--recent advances in pathogenesis and treatment]

No To Shinkei. 2002 Jan;54(1):5-21.

[Article in Japanese]

Authors

Yasuto Itoyama¹, Kazuo Fujihara, Ichiro Nakashima, Takeo Misu, Toshikazu Fujimori, Shigeru Sato

Affiliation

¹ Department of Neurology, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980-8574, Japan.

PMID: 11868352

No abstract available

Publication types

Review

MeSH terms

Autoimmunity
Azathioprine / therapeutic use
Cytokines / physiology
Glatiramer Acetate
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunosuppressive Agents / therapeutic use
Interferon beta-1a
Interferon-beta / therapeutic use
Multiple Sclerosis / etiology*
Multiple Sclerosis / genetics
Multiple Sclerosis / therapy*
Myelin-Associated Glycoprotein / physiology
Myelitis, Transverse / physiopathology
Optic Neuritis / physiopathology
Peptides / therapeutic use
T-Lymphocytes / immunology

Substances

Cytokines
Immunoglobulins, Intravenous
Immunosuppressive Agents
Myelin-Associated Glycoprotein
Peptides
Glatiramer Acetate
Interferon-beta
Azathioprine
Interferon beta-1a